Evaluation of Procalcitonin and CRP in Diagnosing Acute Pelvic  Inflammatory Disease

Iram Shahzadi, Farina Hayat, Ambreen Nasir, Nazia Muneer, Sidra Afzal, Sehrish Sabir

Evaluation of Procalcitonin and CRP in Diagnosing Acute Pelvic Inflammatory Disease

Authors

Iram Shahzadi, Farina Hayat, Ambreen Nasir, Nazia Muneer, Sidra Afzal, Sehrish Sabir

Keywords:

pelvic inflammatory disease, procalcitonin, C-reactive protein, biomarkers, diagnosis

Abstract

Acute pelvic inflammatory disease (PID) is a common gynecological emergency resulting frominfection and inflammation of the upper genital tract. Early diagnosis is essential to preventcomplications such as infertility, ectopic pregnancy

References

Zhao H, et al. Diagnostic utility of biomarkers in pelvic infections. J Gynecol Obstet Hum Reprod. 2021;50(6):102048.

Kim Y, et al. Procalcitonin in gynecological infections. Clin Exp Obstet Gynecol. 2022;49(3):55–62.

Downloads

Published

2025-08-30

How to Cite

Iram Shahzadi, Farina Hayat, Ambreen Nasir, Nazia Muneer, Sidra Afzal, Sehrish Sabir. (2025). Evaluation of Procalcitonin and CRP in Diagnosing Acute Pelvic Inflammatory Disease. International Journal of Pharmacy Research & Technology (IJPRT), 15(2), 1695–1702. Retrieved from https://www.ijprt.org/index.php/pub/article/view/952